To evaluate, using a rat model of non‐bacterial prostatic inflammation, the prostaglandin production and expression profiles of E‐series prostaglandin (EP) receptor subtypes, which are reportedly implicated in the development of… Click to show full abstract
To evaluate, using a rat model of non‐bacterial prostatic inflammation, the prostaglandin production and expression profiles of E‐series prostaglandin (EP) receptor subtypes, which are reportedly implicated in the development of overactive bladder, in the bladder mucosa, and to investigate the effect of EP receptor type 4 (EP4) blockade on bladder overactivity after prostatic inflammation.
               
Click one of the above tabs to view related content.